IP Library Granted Patent US 9,545,378
Granted Patent B2
US 9,545,378 · App. 13/718,639 · Granted Jan 17, 2017

Aerosol valve

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,545,378
App. No.
13/718,639
Granted
Jan 17, 2017
Kind
B2
Abstract

Method for producing a microfoam suitable for use in scleropathy of blood vessels by introducing a physiologically acceptable blood-dispersible gas into a container holding an aqueous sclerosant liquid and releasing the mixture of blood-dispersible gas and sclerosant liquid such that, upon release of the mixture, the components of the mixture interact to form a microfoam. The container is provided with a steam-sterilizable aerosol valve having a valve body of polymeric material having an HDT (heat deflection temperature) at 1.8 MPa stress in the range of 200-275 ° C.

Claims (10)

1. A method for producing a microfoam suitable for use in scleropathy of blood vessels, comprising introducing a physiologically acceptable blood-dispersible gas into a container holding an aqueous sclerosant liquid and releasing the mixture of blood-dispersible gas and sclerosant liquid, whereby upon release of the mixture the components of the mixture interact to form a microfoam, the container being provided with a steam-sterilizable aerosol valve having a valve body of polymeric material, wherein the valve body consists of a polymeric material having an HDT (heat deflection temperature) at 1.8 MPa stress in the range of 200-275° C.

2. A method as claimed in claim 1 , wherein the sclerosant liquid is a solution of polidocanol or sodium tetradecyl sulfate in an aqueous carrier.

3. A method as claimed in claim 2 , wherein the solution is from 0.25 to 5% vol/vol polidocanol.

4. A method as claimed in claim 1 , wherein the mixture of blood-dispersible gas and sclerosant liquid is pressurized to a pre-determined level in the range 800 mbar to 4.5 bar gauge (1.8 bar to 5.5 bar absolute).

5. A method as claimed in claim 4 , wherein the pressure is in the range of 1 bar to 2.5 bar gauge.

6. A method as claimed in claim 1 , wherein the microfoam is such that less than 20% of the bubbles are less than 30 μm diameter, greater than 75% are between 30 and 280 μm diameter, less than 5% are between 281 and 500 μm diameter, and there are substantially no bubbles greater than 500 μm diameter.

7. A method as claimed in claim 1 , wherein the gas/liquid ratio in the mix is controlled such that the density of the microfoam is 0.07 g/ml to 0.19 g/ml.

8. A method as claimed in claim 1 , wherein the microfoam has a half-life of at least 2 minutes.

9. A method as claimed in claim 1 , wherein the steam-sterilizable aerosol valve comprises a valve body that consists of polyphenylsulphone (PPSU).

10. A method as claimed in claim 1 , wherein the steam-sterilizable aerosol valve comprises a valve body, a valve insert and a stem valve that consist of polyphenylsulphone (PPSU).

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2023
From: BTG INTERNATIONAL LIMITED
To: PROVENSIS LIMITED
Reel/Frame 065731/0815 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2023
From: PROVENSIS LIMITED
To: BOSTON SCIENTIFIC MEDICAL DEVICE LIMITED
Reel/Frame 065742/0268 →
CHANGE OF ADDRESS CERTIFICATE Recorded May 28, 2014
From: BTG INTERNATIONAL LIMITED
To: BTG INTERNATIONAL LIMITED
Reel/Frame 033044/0001 →